Brainscape's Knowledge GenomeTM

Browse over 1 million classes created by top students, professors, publishers, and experts.


See full index

CVS > CVS 8 and 9 - Haemostasis and Thrombosis > Flashcards

CVS 8 and 9 - Haemostasis and Thrombosis Flashcards

1
Q

What are the 2 general functions of haemostasis?

A
  1. Prevent blood loss from intact vessels

2. Arrest bleeding from injured vessels

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Define coagulation.

A

Process by which blood converted from liquid to solid state

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Explain the 2 ways in which platelet adhesion can occur.

A
  1. When damage occurs to endothelial cells, sub endothelial layer is exposed (rich in collagen).
  • > Method 1 - VWF (in small vessels with high shear stress)
    1. Collagen can be recognised through Von Willebrand factor which binds to collagen and attracts platelets.
    2. Platelets bind to Glycoprotein 1b receptor on VWF and become activated
  • > Method 2 - Occurs in larger vessels with lower shear stress.
    1. Glycoprotein 1A on platelets directly bind to collagen and become activated.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What happens after platelet adhesion has occurred?

A
  1. Activated platelets release ADP and Prostaglandins (particularly thromboxane).
  2. Platelet aggregation now occurs. Glycoprotein 2B/3A receptors are activated on the platelet and fibrinogen can bind to them (fibrinogen acts as a glue clumping the platelets together).
  3. Thrombin (protease) generated which can directly activate platelets to aggregate.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Name 3 things that activated platelets do.

A
  1. Change shape
  2. Changes membrane composition (certain phospholipids inside the platelet come to the outside - they binds to the coagulation factors)
  3. They present new/activated proteins on their surface (e.g. GP 2B/3A to react with fibrinogen)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What is a platelets lifespan

A

8 days

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Where are clotting factors, fibrinolytic factors and inhibitors synthesised? (3 SITES)

A
  1. Liver (majority)
  2. Endothelial cells (VWF particularly)
  3. Megakaryocytes (then packaged in the platelets)- Factor 5 is made in the megakaryocyte
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Where is Tissue plasminogen activator (tPA) synthesised and what is its role?

A

Synthesised locally in endothelial cells, near to where the clot forms.

Role of tPA is to convert inactive plasminogen to plasmin.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

How does dissolution of the clot occur?

A

1 Fibrin clot assembles plasminogen and tPA on its surface.

  1. tPA can now cleave plasminogen into plasmin.
  2. Plasmin is a proteolytic enzyme - can break down fibrin clot.
  3. Products of breakdown are Fibrin Degradation Products (FDPs).
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

How can tPA be used in therapy for treating MIs?

A

Combine with a bacterial activator (streptokinase).

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What are the 2 Coagulation inhibitory mechanisms?

A
  1. Direct inhibition

2. Indirect inhibition

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Explain direct inhibition.

A
  1. Antithrombin (3) - broad scale inhibitor which circulates in high concentrations. Inhibits most of the coagulation proteinases (not just thrombin)
  2. So antithrombin inhibits coagulation proteinases involved in the coagulation cascade (e.g. 11A, 9A, 10A, Thrombin (2A), etc.
  3. Antithrombin works by forming an inactive complex with coagulation factors and they are then cleared from circulation.

(HEPARIN ACCELERATES ANTITHROMBIN ACTION - hence used in anticoagulation in venous thrombosis/pulmonary embolism)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Explain indirect inhibition.

A
  1. Mechanism to slow down amount of thrombin that is generated. Involves protein C pathway and protein C anticoagulant pathway.
  2. Factors 5 and 8 are activated by trace amounts of thrombin - they make the coagulation cascade occur faster. Important acceleratory mechanism for thrombin formation.
  3. The formed thrombin then binds to Thrombomodulin (surface of endothelium) - changes the conformation of thrombin.
  4. Changed conformation of thrombin means Protein C is activated (and Protein C binds to thrombomodulin receptor). From here, Activated Protein C and Protein S (a cofactor) proteolytically inactivate Factors 5a and 8a.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What is factor 5 Leiden?

A

A common polymorphism (4% population) whereby their Factor 5a is not so easily inactivated.

Hence protein C inactivation pathway cannot inactivate Factor 5 Leiden so higher thrombosis risk.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

What are 4 risk factors for thrombosis?

A
  1. Antithrombin deficiency
  2. Protein C deficiency
  3. Protein S deficiency
  4. Factor V Leiden
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

In normal haemostasis, what is the balancing act between?

A

(Fibrinolytic factors, anticoagulant proteins) vs coagulation factors, platelets

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

What is primary haemostasis?

A

Formation of unstable platelet plug.

(i.e. there could be something wrong with collagen, VWF, platelets).

18
Q

Primary haemostasis is caused by defective/deficient:

  1. Collagen
  2. VWF
  3. Platelets

Give examples of how these deficiencies may arise

A
  1. Collagen - vessel wall

Steroid therapy makes collagen & vessel wall weak. Aging also weakens vessel wall. Scurvy.

  1. VWF - genetic deficiency
  2. Platelets - aspirin/other drugs. Thrombocytopenia = relative decrease in platelet count in blood
19
Q

How can a failure in primary haemostasis occur

A
  1. If one has no VWF, platelets fly past the damaged endothelium and so cannot form a primary plug,
20
Q

Name some defects/patterns of primary haemostasis.

NIGPEB

A
  1. (Prolonged) Nosebleeds.
  2. Immediate
  3. Gum bleeding
  4. Petechiae
  5. Easy bruising
  6. Menorrhagia (anaemia)
21
Q

Explain briefly petechiae (JOE WELLER)

A

Small blood spots appearing in thrombocytopenic patients.

Appear spontaneously. Platelets constantly repairing damaged endothelium, and a lack of platelet manifests as petechiae.

22
Q

What is secondary haemostasis?

A

Generation of thrombin from prothrombin.

Thrombin then converts fibrinogen into fibrin.

Fibrin forms the insoluble mesh around the platelets

23
Q

How come haemophiliacs do not get clot stabilisation?

Haemophilia is a failure in secondary haemostasis.

Especially prominent in larger blood vessels.

A

They lack Factor 8/9.

This means that there is a failure of the thrombin burst (produced in normal individuals).

A much slower increase in thrombin means that fibrinogen is not converted to fibrin as much, meaning that not enough fibrin mesh is formed. Therefore clot not stabilised.

24
Q

Give common examples of defects of secondary haemostasis.

A

Anything causing a defect/deficiency in Factors 1-13.

  1. Haemophilia - F8/9
  2. Liver disease
  3. Drugs
  4. Dilution
  5. Consumption
25
Q

Briefly describe Dessminated Intravascular Coagulation.

A
  1. Generalised activation of coagulation (Tissue Factor is everywhere). TF should NOT usually be in circulation, only exposed when endothelial wall breaks down.
  2. All Coagulation factors used up, fibrinogen etc used up due to fibrinolysis.
  3. Associated with inflammation/sepsis/tissue damage
  4. May cause widespread bleeding, bruising, etc.
  5. Depositing fibrin in vessels can cause organ failure.
26
Q

What is the pattern of bleeding for those with secondary haemostasis?

A
  1. Delayed (unlike primary)
  2. Prolonged
  3. Deeper - joints and muscles
  4. Small cuts usually do not cause excessive bleeding (As primary haemostasis is safe)
  5. Nosebleeds rare
  6. Bleeding after trauma/injury.
  7. Bleeding after intramuscular injections
27
Q

What is a hallmark of haemophilia (A and B)?

A

Haemarthrosis.

Bleeding into joints - causes pressure buildup and is painful.

28
Q

What are some occasions that may cause excess fibrinolysis?

A
  1. Excess fibrinolytic things (plasmin, tPA). Caused by therapeutic administration, tumours
  2. Deficient antifibrinolytic things (antiplasmin deficiency)
  3. Excess anticoagulant. Usually due to heparin, thrombin inhibitors or F10 inhibitors (i.e. therapy)
29
Q

What is fibrinolysis?

A

Vessel repair and dissolution of clot.

30
Q

What are the 2 effects of thrombosis?

A
  1. Obstructed flow of blood

2. Embolism

31
Q

What is the prevalence of venous thromboembolism?

A

1 in 1000 - 10,000 per year.

Incidence doubles every decade

PE is the cause of 10% of hospital deaths

32
Q

What are some consequences of thrombo-embolism?

A
  1. Valve damage - meaning more stasis
  2. Thrombophlebitic syndrome - swelling/ulcers in the leg due to damage
  3. Pulmonary hypertension
33
Q

What factors contribute to getting a thrombosis?

A
  1. Genetic constitution
  2. Effect of age/illnesses/medication, etc
  3. Acute stimulus (e.g. long haul flight).

If above thrombotic threshold, you will get a thrombosis

34
Q

Virchows Triad ?

A
  1. Blood (coagulativity) - dominant in venous thrombosis
  2. Vessel wall - dominant in arterial thrombosis
  3. Flow (stasis) - complex, involved in both

(faster blood flow = more activated coagulation factors get swept away - less chance of thrombus forming)

35
Q

How can blood (coagulativity) increase risk of thrombosis?

A
  1. Deficiency in anticoagulant proteins (e.g. antithrombin, protein C, protein S)
  2. Increase in coagulative proteins (F8, F2/others, F5 Leiden, Thrombocytosis) which increases hypercoagulability
36
Q

How can vessel wall impact risk of thrombosis?

A

(we know less about this)

  1. Many important coagulative proteins found on surface of endothelial cells.
    - Thrombomodulin
    - TF
    (-TF pathway inhibitor)

Usually, vessel wall exhibits anticoagulative role

  1. Inflammation downregulates the anticoagulant properties (e.g. thrombomodulin) and upregulates procoagulant properties of vessel wall.
37
Q

How can flow impact risk of thrombosis?

A

Reduced flow = increased risk of venous thrombosis

Can be caused by surgery, fracture, long haul flights, bed rest, etc

38
Q

Give some examples of conditions that can alter blood coagulation and increase risk of thrombosis.

A
  1. Pregnancy
  2. Malignancy
  3. Surgery
  4. Inflammatory response
39
Q

What therapy can we give for venous thrombosis?

A
  1. Help lyse clot by giving tPA (increased risk of bleeding)
  2. Limit recurrence/extension emboli - increase anticoagulant activity (e.g. heparin), decrease procoagulant factors, use anticoagulants that are direct inhibitors.
40
Q

When is the only circumstance whereby thrombolytic therapy is given after a thrombosis?

A

If a stroke occurs.

Not done more often due to increased risk of bleeding

To prevent clotting - increase anticoagulant activity (heparin) and decrease procoagulant activity

CVS (16 decks)

Brainscape helps you reach your goals faster, through stronger study habits.
© 2024 Bold Learning Solutions. Terms and Conditions